NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
TORONTO and HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic…
ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery
TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic…
Biologic Pharmamedical Expands Manufacturing Flexibility to Meet Customer Demand
February 25, 2025 11:00 ET | Source: Biologic Pharmamedical Inc. VANCOUVER, British…
EpiVax Drives Immunogenicity Innovation in 2024: Year in Review
PROVIDENCE, R.I., Dec. 7, 2024 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical…
Biologic Pharmamedical Reveals Capryl-Butyrate and necessary lifestyle changes for natural solutions for Gut Health, Mental Clarity, and Age-Defying Wellness
VANCOUVER, British Columbia, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Biologic Pharmamedical™ Research…